In the quiet chemistry of a test tube, and then inside living human cells, a pair of immune molecules was seen to gather into drifting droplets, much as oil separates and beads within water. Researchers at UT Southwestern, working in the lab of James Chen, have offered a physical picture of how the body's defenses are summoned into action: not by rigid machinery alone, but by matter condensing into compartments that need no walls. Their report, published in Molecular Cell, answers a question that had lingered for years, namely how the chains of ubiquitin and the protein NEMO come together to a
Immune Switch Found in Cellular Droplets: Protein Clusters Drive Inflammatory Response
Compartments without needing membranes to surround them
Mark
So what actually happened here? Proteins clumped into droplets?
Mimi
Yes. NEMO and chains of ubiquitin gathered into liquid droplets, and inside those droplets the IKK complex got activated and sent NF-kB to the nucleus.
Mark
Why does the droplet matter, as opposed to just the proteins?
Mimi
Chen calls them microreactors. They concentrate proteins and their substrates without needing a membrane around them.
Luke
That's his description, though. What did the experiments show directly?
Mimi
Droplets in test tubes, and the same phase separation in human cells exposed to IL-1b or TNFa. Longer chains gave larger droplets and a stronger response.
Mark
And the disease link?
Mimi
NEMO with mutations tied to NEMO deficiency syndrome couldn't condense properly with the chains, and the immune cascade didn't start.
Luke
Careful with the leap to treatment. The report says better understanding could eventually lead to therapies. Nothing has been tested in patients.
Mark
So it's a mechanism, not a drug.
Luke
Right. And the source doesn't say how a droplet might be adjusted safely, or how many people it could help.
Mimi
What's solid is the explanation of a gap that stood open for over twenty years: how the pieces come together.
The Pulse
- Inside the cell, immune proteins NEMO and polyubiquitin chains are condensing into liquid droplets that act like membraneless workshops.
- Those droplets activate the IKK complex, which sends NF-kB rushing into the nucleus to switch on hundreds of immune genes.
- Longer ubiquitin chains build larger droplets and stronger responses, revealing a measurable dial on the strength of immunity.
- Mutated NEMO from a rare deficiency syndrome fails to condense, cutting the signal chain before it can start, which points to a clear target.
- The findings so far rest on test tubes and human cells, so therapies for deficiency and for overactive or underactive immunity remain a prospect still being explored.
In the quiet chemistry of a test tube, and then inside living human cells, a pair of immune molecules was seen to gather into drifting droplets, much as oil separates and beads within water. Researchers at UT Southwestern, working in the lab of James Chen, have offered a physical picture of how the body's defenses are summoned into action: not by rigid machinery alone, but by matter condensing into compartments that need no walls. Their report, published in Molecular Cell, answers a question that had lingered for years, namely how the chains of ubiquitin and the protein NEMO come together to awaken the signals that bring immune genes to life. The implications reach toward people whose immune systems respond too weakly or too strongly, though for now these are hopes built on laboratory evidence rather than cures.
In test tubes at UT Southwestern Medical Center, researchers mixed NEMO, a key immune protein, with chains of ubiquitin, and watched them gather into liquid droplets that held themselves apart from the fluid around them, the way oil beads in water. The study, published in Molecular Cell, gives a physical picture of how a cell switches on its immune defenses.
The work comes from the laboratory of James Chen, whose team decades ago discovered that ubiquitin forms chains inside cells exposed to inflammatory signals. Those chains were known to help activate the IKK complex, which releases NF-kB into the nucleus. What remained unclear was how the chains, NEMO and IKK first came together.
When the team combined these ingredients with TRAF6, a protein that builds the chains, the droplets formed. Human cells showed the same behavior after exposure to inflammatory molecules. Once IKK entered the droplets, it became active and sent NF-kB to the nucleus. The longer the chains, the larger the droplets and the stronger the response.
The researchers also studied NEMO carrying mutations found in a rare condition that leaves people vulnerable to bacterial infection. That altered protein could not condense properly, so the signaling cascade never began. Chen suggested that understanding this liquid phase separation might one day help treat that syndrome and calibrate immunity that runs too high or too low. For now, however, these remain findings from test tubes and cells, and any therapy is still ahead.
In test tubes at UT Southwestern Medical Center, researchers mixed two ingredients of the immune system, a protein called NEMO and chains of another protein called ubiquitin, and watched them gather into liquid droplets that stayed apart from the fluid around them, the way oil beads up in water. The finding, published in the journal Molecular Cell, offers a physical picture of how a cell switches on an immune response.
The work comes from the lab of Zhijian "James" Chen, Ph.D., a professor of molecular biology and director of the Center for Inflammation Research at UT Southwestern. Chen is also a Howard Hughes Medical Institute Investigator and won the 2019 Breakthrough Prize in Life Sciences. His lab discovered more than two decades ago that ubiquitin assembles into chains inside cells exposed to inflammatory molecules such as interleukin-1b (IL-1b) or tumor necrosis factor a (TNFa).
Chen and colleagues went on to show that those chains are key to promoting an immune response. They can activate a group of proteins called the IkB complex, or IKK, which includes NEMO. Once active, the complex sends a protein called NF-kB into the cell nucleus, where it turns on hundreds of immune-related genes. What remained unclear was how the polyubiquitin chains, NEMO and IKK come together in the first place.
To test it, the team combined ubiquitin and NEMO in test tubes with TRAF6, a protein that prompts ubiquitin to form chains. NEMO and the chains assembled into liquid droplets, separate from the surrounding medium. Experiments in human cells showed the same behavior, known as phase separation, after the cells were exposed to IL-1b or TNFa. When IKK entered the droplets, it became activated and triggered NF-kB to move into the nucleus.
Length mattered. According to Chen, the longer the polyubiquitin chains, the larger the droplets they formed with NEMO, and the stronger the immune response that followed. He described the droplets as microreactors that concentrate proteins and the substances they act on, forming compartments without needing membranes around them.
The researchers also examined NEMO carrying mutations linked to a rare condition called NEMO deficiency syndrome, which severely blunts the immune response to bacterial infections. That altered NEMO could not condense effectively into droplets with polyubiquitin chains, which prevented the cascade of events that sets off an immune response.
Chen noted that a better grasp of this liquid phase separation could eventually lead to treatments for NEMO deficiency syndrome, and to ways of counteracting overactive or underactive immunity. Those states underlie autoimmune disorders and increased susceptibility to infection, respectively. For now the evidence comes from test tubes and human cells, and any therapy remains a prospect rather than a result.
Notable Quotes
The droplets function as microreactors that concentrate proteins and their substrates, forming compartments without membranes.— Zhijian "James" Chen, Ph.D., UT Southwestern
Want the full story?
Read the original at Devdiscourse ↗
Science & Space